Long-term endothelin receptor antagonist administration improves alterations in expression of various cardiac genes in failing myocardium of rats with heart failure

Circulation

Volumn 101, Issue 24, 2000, Pages 2849-2853

  Sakai, Satoshi ^a   Miyauchi, Takashi ^a   Yamaguchi, Iwao ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Endothelin; Genes; Heart failure

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; ADENOSINE TRIPHOSPHATASE (CALCIUM); ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ATRIAL NATRIURETIC FACTOR; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN RECEPTOR ANTAGONIST; MYOSIN HEAVY CHAIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; GENE EXPRESSION; HEART FAILURE; HEART MUSCLE; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL;

EID: 0034691270     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.24.2849     Document Type: Article

References (25)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332: 411-415.
2. Miyauchi T, Masaki T. Pathophysiology of endothelin in cardiovascular system. Annu Rev Physiol. 1999;61:391-415.
3. Miyauchi T, Yorikane R, Sakai S, et al. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res. 1993;73: 887-897.
4. Stawski G, Olsen UB, Grande P. Cytotoxic effect of endothelin-1 during 'stimulated' ischaemia in cultured myocytes. Eur J Pharmacol. 1991; 201:123-124.
5. Ishikawa S, Miyauchi T, Sakai S, et al. Elevated levels of plasma endothelin-1 in young patients with pulmonary hypertension caused by congenital heart disease are decreased after successful surgical repair. J Thorac Cardiovasc Surg. 1995;110:271-273.
6. Tsutamoto T, Hisanaga T, Fukai D, et al. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure. Am J Cardiol. 1995;76: 803-808.
7. Margulies KB, Hildebrand FL Jr, Lerman A, et al. Increased endothelin in experimental heart failure. Circulation. 1990;82:2226-2230.
8. Sakai S, Miyauchi T, Sakurai T, et al. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure: marked increase in endothelin-1 production in the failing heart. Circulation. 1996;93:1214-1222.
9. Sakai S, Miyauchi T, Kobayashi M, et al. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature. 1996;384:353-355.
10. Mulder P, Richard V, Derumeaux G, et al. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling. Circulation. 1997;96:1976-1982.
11. Oie E, Bjonerheim R, Grogaard HK, et al. ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats. Am J Physiol. 1998;44:H868-H877.
12. Yamauchi-Kohno R, Miyauchi T, Hoshino T, et al. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin A antagonist on survival and cardiac function. Circulation. 1999;99: 2171-2176.
13. Wada A, Tsutamato T, Ohnishi M, et al. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism. Circulation. 1999;99:570-577.
14. Iwanaga Y, Kihara Y, Hasegawa K, et al. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive rats. Circulation. 1998;98:2065-2073.
15. Schwanz K, Chassagne C, Boheler KR. The molecular biology of heart failure. J Am Coll Cardiol. 1993;22:30A-33A.
16. Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res. 1994;74:555-564.
17. Pieruzzi F, Abassi ZA, Keiser HR. Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation. 1995;92:3105-3112.
18. Feldman AM, Ray PE, Silan CM, et al. Selective gene expression in failing human heart: quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation. 1991;83:1866-1872.
19. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarct size and ventricular function in rats. Circ Res. 1979;44:503-512.
20. Sakai S, Miyauchi T, Sakurai T, et al. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist: increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats. J Am Coll Cardiol. 1996;28: 1580-1588.
21. B receptors, endothelin-converting enzyme and the cellular distribution of endothelin-1 staining in the failing heart due to myocardial infarction in rats. Am J Physiol. 1999;276:H1197-H1206.
22. Maeda S, Miyauchi T, Kobayashi T, et al. Exercise causes tissue-specific enhancement of endothelin-1 mRNA expression in internal organs. J Appl Physiol. 1998;85:425-431.
23. Miyauchi T, Kobayashi T, Yamauchi R, et al. Cloning of hamster preproendothelin-1 cDNA and its expression in the heart. J Cardiovasc Pharmacol. 1998;31:S298-S301.
24. B receptor antagonist. Circulation. 1996;93:2068-2079.
25. Meggs LG, Coupet J, Huang H, et al. Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ Res. 1993;72:1149-1162.